Skip to main content
VulnerabilityPublished

CVE-2026-10534: IBM Db2 · Stack-based Buffer Overflow

Affects IBM Db2Source CVE Database V5

0
Compare

Not known to be exploited · CVSS 8.4 High.

Data as of 10 Nov 2026, 23:24 UTC

CVSS 3.1 base score
8.4High
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.3% chance of exploitation in 30 days – higher than 31% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 12 Aug 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 10 Nov 2026.

What to do

Affected software

ProductAffectedFixed in
IBMDb2Affected
  • >=11.5.0 <=11.5.9
  • >=12.1.0 <=12.1.5
Fixed in–
Mavencom.ibm/db2pkg:maven/com.ibm/db2Other threatsAffected
  • =11.5.0
  • <=11.5.9
  • >=12.1.0
  • <=12.1.5
Fixed in–

CPE configurations (4)

  • cpe:2.3:a:ibm:db2:11.5.0:*:*:*:*:*:*:*
  • cpe:2.3:a:ibm:db2:11.5.9:*:*:*:*:*:*:*
  • cpe:2.3:a:ibm:db2:12.1.0:*:*:*:*:*:*:*
  • cpe:2.3:a:ibm:db2:12.1.5:*:*:*:*:*:*:*

Check your own hosts for these packages with threat-finder (opens in a new tab), our free open-source scanner.

AI-suggested

Until a patch is available, restrict access to the affected Db2 versions to trusted users only and monitor for unusual activity related to IXF IMPORT operations.

Description

IBM Db2 11.5.0 through 11.5.9, and 12.1.0 through 12.1.5 is vulnerable to buffer overflow in the IXF IMPORT parser.

References

Community reviews

Loading reviews…